OpenVSafe by OpenVAERS
Search V-safe

YCB-25272-95124

3 vaccinations 2 coded responses 13 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
352 / AL
Registered
2021-06-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  3. 2021-06-24
    Registered in v-safe
  4. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  5. 2021-10-08
    Dose 3 — Pfizer-BioNTech
  6. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches
    Adult check-in
  7. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  8. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  9. 2021-10-14
    Survey response — days 1–6 daily, dose 3
    MedDRA: Paranasal sinus hypersecretion — Feeling: Fair · Chills, Headache · Be unable to do your normal daily activities
    Free text: Sinus Drainage
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-10-15
    Health check-in — day 7, dose 3
    Feeling: Good · Nausea
    Adult check-in
  11. 2021-10-22
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2021-10-29
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-11-05
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-11-12
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-11-19
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-01-07
    Survey response — 3 months, dose 3
    MedDRA: Anxiety, Chest pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Chest pain due to anxiety
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-07
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  18. 2022-01-11
  19. 2022-01-13
  20. 2022-04-08
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-26Pfizer-BioNTech No
22021-01-19Pfizer-BioNTech No
32021-10-08Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-01-07 Unsuccessful

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-14

Systemic reaction (other): Sinus Drainage

Release 10 — 3 months, dose 3

2022-01-07

Symptoms: Chest pain due to anxiety

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety · · ✓
SDChest pain · · ✓
SROParanasal sinus hypersecretion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release